# Shenzhen Dartmon Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shenzhen-dartmon-biotechnology-co

- Industry: Medical Devices & Equipment
- Headquarters: Shenzhen, China
- Website: www.dartmon.com
- Latest round: Series A (Dec 17, 2021)
- Investors on record: 4

## About

Established in 2018 and based in Shenzhen, China, Shenzhen Dartmon Biotechnology Co., Ltd. is a medical health company focus on research, development, production, sales and service of tumor pathology diagnostic instruments and reagents. The company raised 2 rounds of funding as of 2021. The founding team comes from well-known medical companies in China and abroad and has very rich experience in the medical industry. More than 30% of employees are engaged in innovation, research and development.

The company's main business is the research and development, production and sales of tumor pathology instruments and reagent products such as immunohistochemical staining systems and fluorescence in situ hybridization. The self developed products include fully automatic immunohistochemical stainer, fully automatic IHC (Immunohistochemistry) stainer AS300/330, in-situ hybridization processor DH100 and antibody products.

The company plan to use the series A funding for expand the company's pathology product line, and further build domestic/international sales and operation teams.

## Funding rounds

- Series A, Dec 17, 2021 — ASB Ventures, Magellan Capital, Bioching Capital
- Angel, Jun 19, 2018 — CD Capital, Bioching Capital

## Investors

- CD Capital — Angel
- Bioching Capital (https://capitalatlas.ai/funds/bioching-capital) — Angel, Series A
- ASB Ventures (https://capitalatlas.ai/funds/asb-ventures) — Series A
- Magellan Capital (https://capitalatlas.ai/funds/magellan-capital) — Series A